RESULTS: From baseline to 12 weeks, compared with placebo, the trial group showed significant reductions in the United Parkinson's Disease Rate Scale (UPDRS) total score (-7.74 5.92 vs. -1.83 4.14, p < 0.001), UPDRS part I (-0.72 0.81 vs. -0.20 0.72, p = 0
…Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1981 | 1 |
2002 | 1 |
2003 | 1 |
2005 | 1 |
2009 | 1 |
2015 | 1 |
2017 | 1 |
2018 | 3 |
2019 | 1 |
2020 | 1 |
2021 | 2 |
2022 | 5 |
2023 | 2 |
2024 | 2 |